10x Genomics Inc - Class A

NASDAQ: TXG
$20.02
+$0.41 (+2.1%)
Closing Price on October 4, 2024

TXG Stock Chart and Intraday Price

TXG Stock Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry LABORATORY ANALYTICAL INSTRUMENTS
Address 6230 STONERIDGE MALL ROAD, PLEASANTON, CA, US
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 5,429.25M USD
Shares Outstanding 105,110,000
10x Genomics Inc is a pioneering life science technology firm based in Pleasanton, California, specializing in developing instruments, consumables, and software for analyzing biological systems. Its innovative product lineup includes the Chromium and Visium platforms, offering solutions for single cell gene expression, immune profiling, and spatial analysis of biological samples. These tools are crucial for researchers in academia, government, and the biopharmaceutical industry, aiming to unlock complex biological insights at the cellular and molecular levels.

TXG Articles

Bear Market Strikes Back: Analysts Upgrade or Downgrade Bed Bath & Beyond, Verizon and More
Thursday's additional top analyst upgrades and downgrades were on Analog Devices, Bed Bath & Beyond, Hasbro, Krispy Kreme, 10X Genomics, Verizon Communications and more.
Chris Lange
Published:

More Problems More Spending: Analysts Upgrade or Downgrade CSX, Qualcomm and More
Friday's additional top analyst upgrades and downgrades included Allogene Therapeutics, CSX, Norfolk Southern, Qualcomm, Toyota and Yelp.
Chris Lange
Published:

Thursday's 10 Premarket Winners and Losers Include Cisco, Palantir and Nvidia
Stocks were trading lower in Thursday's premarket. Here is a look at the leaders and the laggards.
Paul Ausick
Published: